Skip to main content
Log in

Uterine balloon therapy for the treatment of menorrhagia

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective(s)

To evaluate the effectiveness of uterine balloon therapy for the treatment of menorrhagia and to determine its prognostic factors.

Method(s)

Seventy five patients were treated with uterine balloon therapy with thermachoice II for intractable menorrhagia without detectable pathology and the results were statistically analyzed regarding procedure efficacy, safety, side effects and prognostic factors at follow-up periods of one month, three months, six months and 12 months.

Results(s)

After undergoing uterine balloon therapy, 41.30% patients attained eumenorrhea, 30.43% hypomenorrhea and 15.21% amenorrhea at the end of 12 months follow-up. Retroverted uterus, prolonged duration of menstruation, endometrial thickness of at least 9mm and uterine depth >10 cm were associated with an increased risk of treatment failure.

Conclusion(s)

Uterine balloon therapy is an efficient and reliable modality to treat women with intractable menorrhagia especially those who have completed their families but do not want to part with their uterus which of course is without any organic pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Amso NN, Stabinsky SA, McFaul P et al. Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study. International Collaborative Uterine Thermal Balloon Working Group. Br J Obstet Gynaecol 1998;105:517–523.

    Article  PubMed  CAS  Google Scholar 

  2. Vilos GA, Fortin CA, Sanders B et al. Clinical trial of the uterine thermal balloon for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 1997;4:559–565.

    Article  PubMed  CAS  Google Scholar 

  3. Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev 2002:CD001124.

  4. Bongers MY, Mol BW, Brölmann HA. Prognostic factors for the success of thermal balloon ablation in the treatment of menorrhagia. Obstet Gynecol 2002;99:1060–1066.

    Article  PubMed  CAS  Google Scholar 

  5. El-Nashar SA, Hopkins MR, Creedon DJ et al. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol 2009;113:97–106.

    PubMed  Google Scholar 

  6. Shaamash AH, Sayed EH. Prediction of successful menorrhagia treatment after thermal balloon endometrial ablation. J Obstet Gynaecol Res 2004;30:210–216.

    Article  PubMed  Google Scholar 

  7. Buckshee K, Banerjee K, Bhatla H. Uterine balloon therapy to treat menorrhagia. Int J Gynaecol Obstet 1998;63:139–143.

    Article  PubMed  CAS  Google Scholar 

  8. Ahonkallio S, Martikainen H, Santala M. Endometrial thermal balloon ablation has a beneficial long-term effect on menorrhagia. Acta Obstet Gynecol Scand 2008;87:107–110.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agarwal, S., Bhargava, A., Chutani, N. et al. Uterine balloon therapy for the treatment of menorrhagia. J Obstet Gynecol India 61, 67–71 (2011). https://doi.org/10.1007/s13224-011-0004-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-011-0004-0

Keywords

Navigation